Web Content
Personalised cancer vaccine expected to be approved next year | New Scientist
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
TypeArticle
Domainwww.newscientist.com
Providernews
Recommend it?





